Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Great Ormond Street Hospital Settles Claim for Girl Whose Brain was allegedly Injected with Glue
  • USA - English


News provided by

Field Fisher Waterhouse LLP - Personal Injury & Medical Negligence Practice

Jan 27, 2014, 12:00 ET

Share this article

Share toX

Share this article

Share toX


London, UK (PRWEB UK) 27 January 2014 -- According to court documents Maisha Najeeb, now aged 13, brought a claim for compensation for treatment received at Great Ormond Street Hospital for the alleged incidental injection of glue into her brain, which left her profoundly brain damaged and blind in one eye.

At the time, Maisha was a healthy 10-year old girl. She has a rare medical condition, arterio-venous malformation ('AVM'), that involves arteries and veins getting tangled and occurs in about 1% of people.

We are sad and devastated by what happened to our daughter. Her life is ruined. All her dreams have been broken. I hope that by bringing this case, lessons will have been learned to avoid this happening to others

Post this

AVMs can be serious when they result in a bleed. However, Maisha was able to lead a very normal life. She had had 5 bleeds that had required treatment by embolisation, which were without complication.

The embolisation procedure involves an injection of glue (an embolic agent) to block off the bleeding blood vessels, and an injection of a harmless dye (contrast) to check the flow of blood around her brain and head.

On 2 June 2010, Maisha had a bleed which required embolisation. According to claims in the law suit, tragically there was no system in place of distinguishing the syringes containing the glue from the syringes containing the contrast, and they got mixed-up in the operating theatre. This the law suit alleges resulted in glue, instead of dye, being wrongly injected into the artery to Maisha's brain. The glue caused catastrophic and permanent brain damage.

Maisha's father instructed Edwina Rawson, medical negligence solicitor and partner at Field Fisher Waterhouse, to pursue a claim for compensation against Great Ormond Street Hospital.

According to court documents Great Ormond Street Hospital admitted negligence and that it had caused all of Maisha's difficulties. Judgment was entered on 1 March 2012 under the case reference TLQ/12/0817.

According to court documents Maisha needs care and assistance with all daily tasks, day and night. She is in a wheelchair and has lost the vast majority of her bodily and cognitive abilities. She suffers from painful leg spasms.

The claim was due to go to trial next month to decide how much compensation Maisha should receive. But at a meeting between the parties, Maisha's lawyers reached an agreement with Great Ormond Street Hospital.

The agreed settlement was for an upfront lump sum payment of £2.8 million, and in addition £383,000.00 per year until Maisha is aged 19. This will then increase to £423,000.00 per year for as long as she lives.

This agreement was approved by the Royal Courts of Justice in London on 27 January 2014. The payments are based upon experts' assessments of Maisha's needs, and will be spent on her care and accommodation.

According to court documents a central issue in the case was the impact that the brain injury and the pre-existing AVM would have on her life expectancy. The parties were not able to reach agreement about this. The life expectancy put forward by the expert for Maisha was 64 years, whereas the defendant's estimated life expectancy was to only age 23. The level of the overall lifetime payment depends on how long she lives as payments will be made yearly.

Edwina Rawson the solicitor said:

"What is so heart-breaking about this case is that the injury was so avoidable. If the syringes had been marked-up so the hospital could see which contained glue and which contained dye, then Maisha would not have suffered what is an utterly devastating brain injury. Such easily avoidable mistakes should not happen."

Sadir Hussain, Maisha's father said:

"We are sad and devastated by what happened to our daughter. Her life is ruined. All her dreams have been broken. I hope that by bringing this case, lessons will have been learned to avoid this happening to other families. We are grateful that agreement has been reached with Great Ormond Street to ensure that Maisha's care needs are met."

Read more about Maisha's case on the Field Fisher Waterhouse Medical Negligence website.
Case Title - Najeeb v Great Ormond Street Hospital For Children NHS Trust
Case Ref - TLQ/12/0817

Sunpreet Chana, Field Fisher Waterhouse LLP - Personal Injury & Medical Negligence Practice, http://www.ffw.com/personalinjury, +44 20 7861 4953, [email protected]

Modal title

Field Fisher Waterhouse - Medical Negligence Review 2012
View PDF
Field Fisher Waterhouse - Medical Negligence Review 2012
Field Fisher Waterhouse - Medical Negligence Review 2013
View PDF
Field Fisher Waterhouse - Medical Negligence Review 2013
Field Fisher Waterhouse - Medical Negligence Review 2012 Field Fisher Waterhouse - Medical Negligence Review 2013

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.